Comparison of early type 2 diabetes improvement after gastric bypass and sleeve gastrectomy: medication cessation at discharge predicts 1-year outcomes
- 1 December 2019
- journal article
- research article
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 15 (12) , 2025-2032
Abstract
No abstract availableKeywords
Funding Information
- National Center for Advancing Translational Sciences
- Harvard Catalyst
This publication has 26 references indexed in Scilit:
- Reprogramming of Intestinal Glucose Metabolism and Glycemic Control in Rats After Gastric BypassScience, 2013
- Clinical Practice Guidelines for the Perioperative Nutritional, Metabolic, and Nonsurgical Support of the Bariatric Surgery Patient—2013 Update: Cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric SurgerySurgery for Obesity and Related Diseases, 2013
- Bariatric Surgery versus Conventional Medical Therapy for Type 2 DiabetesNew England Journal of Medicine, 2012
- Weight-Independent Changes in Blood Glucose Homeostasis After Gastric Bypass or Vertical Sleeve Gastrectomy in RatsGastroenterology, 2011
- The Importance of Caloric Restriction in the Early Improvements in Insulin Sensitivity After Roux-en-Y Gastric Bypass SurgeryDiabetes Care, 2010
- Metabolic Surgery to Treat Type 2 Diabetes: Clinical Outcomes and Mechanisms of ActionAnnual Review of Medicine, 2010
- Mechanisms of early improvement / resolution of type 2 diabetes after bariatric surgeryDiabetes & Metabolism, 2009
- How Do We Define Cure of Diabetes?Diabetes Care, 2009
- Improvement in Glucose Metabolism After Bariatric Surgery: Comparison of Laparoscopic Roux-en-Y Gastric Bypass and Laparoscopic Sleeve GastrectomyAnnals of Surgery, 2009
- Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysisThe American Journal of Medicine, 2009